Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.4K
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

10.0K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
10.0K
Cancer Therapies02:49

Cancer Therapies

7.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Catalytic Asymmetric Nucleophilic Amination and Kinetic Resolution of α-Bromo-acylpyrazoles.

Organic letters·2026
Same author

An In Situ-Generated Near-Infrared Chemiluminescent Nanoprobe for High-Contrast Lymph Node Mapping and Tumor-Guided Surgery.

Analytical chemistry·2026
Same author

Advances in targeted therapies for pediatric tumors.

Acta pharmacologica Sinica·2026
Same author

Engineering Coumarin-Based Afterglow Luminescence Probes for Activatable Imaging Peroxynitrite In Vivo.

Angewandte Chemie (International ed. in English)·2026
Same author

In Vivo-Assembled Artificial Base-Albumin Platform for Tumor-Targeted General Drug Delivery.

ACS nano·2026
Same author

Enantioselective Synthesis of Isoquinuclidine Analogs by Synergistic Copper/Amine-Catalyzed Sequential [3 + 3]/[4 + 2] Cycloaddition.

Angewandte Chemie (International ed. in English)·2026

Related Experiment Video

Updated: May 23, 2025

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
14:20

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Published on: June 13, 2014

16.6K

Bisboronic Ester-Enabled Redox-Targeted Cancer Therapy: A Cascade ROS Consumption Approach for Efficient Elimination

Silin Huang1,2, Yue Cui3, Boqiang Wang4

  • 1Faculty of Life Science and Technology, Kunming University of Science and Technology, Kunming, Yunnan 650500, P. R. China.

Journal of Medicinal Chemistry
|March 7, 2025
PubMed
Summary

Researchers developed novel bisboronic esters that selectively target and eliminate cancer cells by disrupting their redox homeostasis. These compounds rapidly deplete reactive oxygen species (ROS), offering a promising new strategy for cancer therapy.

More Related Videos

Harnessing the Bioorthogonal Inverse Electron Demand Diels-Alder Cycloaddition for Pretargeted PET Imaging
10:47

Harnessing the Bioorthogonal Inverse Electron Demand Diels-Alder Cycloaddition for Pretargeted PET Imaging

Published on: February 3, 2015

8.7K
Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction
09:44

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction

Published on: January 29, 2019

10.0K

Related Experiment Videos

Last Updated: May 23, 2025

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
14:20

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Published on: June 13, 2014

16.6K
Harnessing the Bioorthogonal Inverse Electron Demand Diels-Alder Cycloaddition for Pretargeted PET Imaging
10:47

Harnessing the Bioorthogonal Inverse Electron Demand Diels-Alder Cycloaddition for Pretargeted PET Imaging

Published on: February 3, 2015

8.7K
Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction
09:44

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction

Published on: January 29, 2019

10.0K

Area of Science:

  • Biochemistry
  • Medicinal Chemistry
  • Oncology

Background:

  • Cancer cells exhibit elevated reactive oxygen species (ROS) due to altered metabolism, presenting a unique therapeutic vulnerability.
  • Redox homeostasis is crucial for cellular function, and its disruption can lead to cell death.

Purpose of the Study:

  • To introduce bisboronic esters as novel agents for disrupting cancer cell redox homeostasis.
  • To evaluate the efficacy and structure-activity relationships of these compounds in selectively eliminating cancer cells.

Main Methods:

  • Synthesis and characterization of bisboronic ester compounds.
  • Structure-activity relationship (SAR) studies to determine optimal compound structures.
  • In vitro cytotoxicity assays to determine IC50 values.
  • Confocal imaging to assess intracellular ROS levels and cellular response.

Main Results:

  • Bisboronic esters were identified as potent agents for rapidly disrupting cellular redox homeostasis.
  • The most effective compounds demonstrated significant cytotoxicity against cancer cells, with IC50 values as low as 0.63 μM.
  • Confocal imaging confirmed rapid intracellular ROS depletion, leading to metabolic imbalance and cancer cell death.

Conclusions:

  • Bisboronic esters represent a novel class of therapeutic agents for redox-targeted cancer therapy.
  • These compounds selectively induce oxidative stress to eliminate cancer cells, highlighting their therapeutic potential.
  • This work provides a foundation for developing innovative boronate-based anticancer strategies.